These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19453722)

  • 1. High resolution micro-SPECT scanning in rats using 125I beta-CIT: effects of chronic treatment with carbamazepine.
    Cain SM; Ruest T; Pimlott S; Patterson J; Duncan R; Dewar D; Sills GJ
    Epilepsia; 2009 Aug; 50(8):1962-70. PubMed ID: 19453722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.
    Reneman L; Booij J; Habraken JB; De Bruin K; Hatzidimitriou G; Den Heeten GJ; Ricaurte GA
    Synapse; 2002 Dec; 46(3):199-205. PubMed ID: 12325046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.
    Lemoine L; Lieberman BP; Ploessl K; Zheng P; Kung HF
    Nucl Med Biol; 2013 Oct; 40(7):879-86. PubMed ID: 23856117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.
    Ryding E; Lindström M; Brådvik B; Grabowski M; Bosson P; Träskman-Bendz L; Rosén I
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1114-8. PubMed ID: 15014902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
    Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
    Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.
    Rominger A; Cumming P; Brendel M; Xiong G; Zach C; Karch S; Tatsch K; Bartenstein P; la Fougère C; Koch W; Pogarell O
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):873-81. PubMed ID: 25819144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of cocaine recognition sites in rat brain: in vitro and ex vivo autoradiography with [125I]RTI-55.
    Fujita M; Shimada S; Fukuchi K; Tohyama M; Nishimura T
    J Chem Neuroanat; 1994 Jul; 7(1-2):13-23. PubMed ID: 7802967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.
    Rothman RB; Silverthorn ML; Glowa JR; Matecka D; Rice KC; Carroll FI; Partilla JS; Uhl GR; Vandenbergh DJ; Dersch CM
    Synapse; 1998 Apr; 28(4):322-38. PubMed ID: 9517841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
    Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF
    J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
    Scanley BE; Baldwin RM; Laruelle M; al-Tikriti MS; Zea-Ponce Y; Zoghbi S; Giddings SS; Charney DS; Hoffer PB; Wang S
    Mol Pharmacol; 1994 Jan; 45(1):136-41. PubMed ID: 8302272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain.
    Günther I; Hall H; Halldin C; Swahn CG; Farde L; Sedvall G
    Nucl Med Biol; 1997 Oct; 24(7):629-34. PubMed ID: 9352533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.
    de Win MM; de Jeu RA; de Bruin K; Habraken JB; Reneman L; Booij J; den Heeten GJ
    Eur Neuropsychopharmacol; 2004 May; 14(3):185-9. PubMed ID: 15056477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.
    Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Schmidl-Mohl B; Wenzel T; Demal U; Zettinig G; Hornik K; Thau K
    Neuropsychopharmacology; 2007 Aug; 32(8):1661-8. PubMed ID: 17192774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain.
    Reneman L; Booij J; Lavalaye J; De Bruin K; De Wolff FA; Koopmans RP; Stoof JC; Den Heeten GJ
    Synapse; 1999 Oct; 34(1):77-80. PubMed ID: 10459174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
    Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
    J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
    Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
    Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.